Brooke E Wilson1,2, Adrian M J Pokorny3,4, Sathira Perera1, Michael B Barton1, Desmond Yip5,6, Christos S Karapetis7, Iain G Ward8, Simon Downes9, Mei Ling Yap1,4,10. 1. Collaboration for Cancer Outcomes, Research and Evaluation, Ingham Institute for Applied Medical Research, South West Clinical School, University of New South Wales, Kensington, New South Wales, Australia. 2. Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. 3. Department of Medical Oncology, Royal Darwin Hospital, Tiwi, Northern Territory, Australia. 4. Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia. 5. Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia. 6. ANU Medical School, Australian National University, Canberra, ACT, Australia. 7. Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australia. 8. Canterbury Regional Cancer and Haematology Service, Christchurch, New Zealand. 9. Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia. 10. Macarthur Cancer Therapy Centre, Western Sydney University, Campbelltown, New South Wales, Australia.
Abstract
AIM: To review the expected increasing demand for cancer services among low and middle-income countries (LMICs) in the Asia-Pacific (APAC), and to describe ways in which Australia and New Zealand (ANZ) can provide support to improve cancer outcomes in our region. METHODS: We first review the current and projected incidence of cancer within the APAC between 2018 and 2040, and the estimated demand for chemotherapy, radiotherapy and surgery. We then explore potential ways in which ANZ can increase regional collaborations to improve cancer outcomes. RESULTS: We identify 6 ways that ANZ can collaborate with LMICs to improve cancer care in the APAC through the ANZ Regional Oncology Collaboration Strategy: Increasing education and institutional collaborations in the APAC region through in-country training, twinning partnerships, observerships and formalised training programs in order to increase cancer care quality and capacity. Promoting and assisting in the establishment and maintenance of population-based cancer registries in LMICs. Increasing research capacity in LMICs through collaboration and promoting high quality global oncology research within ANZ. Engaging and training Australian and New Zealand clinicians in global oncology, increasing awareness of this important career path, and increasing health policy engagement. Increasing web-based endeavours through virtual tumour boards, web-based advocacy platforms and web-based teaching programs. Continuing to leverage for funding through professional bodies, government, industry, not-for-profit organisations and local hospital funds. CONCLUSION: We propose the creation of an Australian and New Zealand Interest Group to provide formalised and sustained collaboration between researchers, clinicians and stakeholders.
AIM: To review the expected increasing demand for cancer services among low and middle-income countries (LMICs) in the Asia-Pacific (APAC), and to describe ways in which Australia and New Zealand (ANZ) can provide support to improve cancer outcomes in our region. METHODS: We first review the current and projected incidence of cancer within the APAC between 2018 and 2040, and the estimated demand for chemotherapy, radiotherapy and surgery. We then explore potential ways in which ANZ can increase regional collaborations to improve cancer outcomes. RESULTS: We identify 6 ways that ANZ can collaborate with LMICs to improve cancer care in the APAC through the ANZ Regional Oncology Collaboration Strategy: Increasing education and institutional collaborations in the APAC region through in-country training, twinning partnerships, observerships and formalised training programs in order to increase cancer care quality and capacity. Promoting and assisting in the establishment and maintenance of population-based cancer registries in LMICs. Increasing research capacity in LMICs through collaboration and promoting high quality global oncology research within ANZ. Engaging and training Australian and New Zealand clinicians in global oncology, increasing awareness of this important career path, and increasing health policy engagement. Increasing web-based endeavours through virtual tumour boards, web-based advocacy platforms and web-based teaching programs. Continuing to leverage for funding through professional bodies, government, industry, not-for-profit organisations and local hospital funds. CONCLUSION: We propose the creation of an Australian and New Zealand Interest Group to provide formalised and sustained collaboration between researchers, clinicians and stakeholders.
Authors: Anneka Parker; Eap Tek Chheng; Titus Nasi; Thyna Orelly; George Aho; Sally Whitaker; James Weaver; Sue Phin; Ruth Baker; Susan Woolfenden; Kathryn Currow Journal: J Paediatr Child Health Date: 2021-06-04 Impact factor: 1.929